文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

非酒精性脂肪肝患者RYGB与袖状胃切除术后肝功能随机对照二次分析

Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
PubMed 文献 · Ann Surg · 2017-01-01

结果显示RYGB术后1个月国际标准化比值(INR)升高幅度显著大于SG,白蛋白下降,但12个月时均恢复基线;在非酒精性脂肪性肝炎(NASH)患者中,SG术后12个月转氨酶及γ-谷氨酰转肽酶显著改善。

要点

  • RYGB术后1个月INR升高较SG更明显,白蛋白下降,12个月恢复基线。
  • NASH患者SG术后12个月AST、ALT、GGT及LDH显著改善。
  • 术后1个月INR变化预测因素包括手术类型、NAS≥5、胆红素、BMI、HbA1c及血脂异常。

核心结论

  • 合并NASH的患者接受RYGB术后比SG术后更易出现早期一过性肝功能恶化。

主要发现

  • NASH在RYGB组占54.5%,SG组占51.5%(P > 0.05)。
  • 12个月多余体重减少率SG组为68.7 ± 19.7%,RYGB组为62.8 ± 18.5%(P > 0.05)。
  • 术后1个月INR在RYGB组由0.98 ± 0.05升至1.14 ± 0.11(P < 0.05),SG组由0.99 ± 0.06升至1.04 ± 0.06(P < 0.05),RYGB组升高幅度显著大于SG组。
  • RYGB组术后1个月白蛋白由41.2 ± 2.7 g/L降至39.0 ± 3.2 g/L(P < 0.05)。
  • NASH患者SG术后12个月AST由32.4 ± 17.4 U/L降至21.5 ± 6.9 U/L,ALT由39.9 ± 28.6 U/L降至23.8 ± 14.1 U/L,GGT由34.3 ± 16.6 U/L降至24.5 ± 16.8 U/L,LDH由510.8 ± 33 U/L降至292.4 ± 29 U/L。

临床怎么用

  • 对合并NASH的减重手术患者,选择RYGB时需警惕术后早期肝功能一过性恶化,加强围术期肝功能监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of the study was to compare the influence of sleeve gastrectomy (SG) versus Roux-en-Y gastric bypass (RYGB) on liver function in bariatric patients with non-alcoholic fatty liver disease (NAFLD) in a randomized clinical trial (NCT01806506). BACKGROUND: Rapid weight loss and malabsorption after bariatric surgery in patients with NAFLD or steatohepatitis (NASH) may impair liver function. METHODS: Sixty-six morbidly obese patients randomized to SG or RYGB were included in a secondary outcome analysis. Intraoperative liver biopsies were categorized with NAFLD Activity Score (NAS) and liver function tests were done before surgery and after 1, 6 and 12 months. RESULTS: NASH was present in 54.5% RYGB and 51.5% SG patients (P > 0.05). At 12 months excess weight loss was 68.7 ± 19.7% after SG and 62.8 ± 18.5% after RYGB (P > 0.05). At 1 month international normalized ratio (INR) increased after RYGB (0.98 ± 0.05 vs 1.14 ± 0.11; P < 0.05) and SG (0.99 ± 0.06 vs 1.04 ± 0.06; P < 0.05), RYGB induced significantly greater increase in INR in the whole group and NASH patients than SG. After RYGB albumin decreased at 1 month (41.2 ± 2.7 vs 39.0 ± 3.2 g/L; P < 0.05). At 12 months, INR and albumin returned to baseline. At 12 months in NASH group, SG induced significant improvement in aspartate aminotransferase (32.4 ± 17.4 vs 21.5 ± 6.9U/L), alanine aminotransferase (39.9 ± 28.6U/L vs 23.8 ± 14.1U/L), gamma-glutamyl transpeptidase (34.3 ± 16.6 vs 24.5 ± 16.8U/L), and lactate dehydrogenase (510.8 ± 33 vs 292.4 ± 29). Variables predictive of INR change after 1 month included operation type, NAS ≥ 5, bilirubin, body mass index, hemoglobin A1C, and dyslipidemia. CONCLUSIONS: Patients with NASH undergoing RYGB are more susceptible to early transient deterioration of liver function than after SG.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, et al. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial. Ann Surg. 2017. PMID: 28767558. doi:10.1097/SLA.0000000000002397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。